Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life

Therapeutic strategy remains unclear with no clear consensus for men with high-risk prostate cancer after radical prostatectomy. We aimed to evaluate into a prospective randomized trial the effectiveness and the feasibility of adjuvant weekly paclitaxel combined with androgen deprivation therapy (AD...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ploussard, Guillaume, Paule, Bernard, Salomon, Laurent, Allory, Yves, Terry, Stéphane, Vordos, Dimitri, Hoznek, Andras, Vacherot, Francis, Abbou, Claude-Clément, Culine, Stéphane, De La Taille, Alexandre
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2891708/
https://ncbi.nlm.nih.gov/pubmed/19935771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2009.51
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller